| pubmed-article:16755175 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0030193 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C1565860 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C1705323 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0538927 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0205214 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
| pubmed-article:16755175 | lifeskim:mentions | umls-concept:C1363844 | lld:lifeskim |
| pubmed-article:16755175 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16755175 | pubmed:dateCreated | 2006-6-6 | lld:pubmed |
| pubmed-article:16755175 | pubmed:abstractText | COX-2 activation may mediate capecitabine induced toxicities, eg, hand-foot syndrome (HFS) and colorectal cancer progression, both of which may be improved by concurrent celecoxib. | lld:pubmed |
| pubmed-article:16755175 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16755175 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16755175 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16755175 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16755175 | pubmed:issn | 1537-453X | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:JanjanNoraN | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:CurleySteven... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:Rodriguez-Big... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:BrownThomasT | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:FeigBarryB | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:LinEdward HEH | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:AyersGregory... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:SkibberJohnJ | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:MorrisJeffrey... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:CraneChristop... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:DelcosMarcM | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:VadhanSaroj-R... | lld:pubmed |
| pubmed-article:16755175 | pubmed:author | pubmed-author:RossAliciaA | lld:pubmed |
| pubmed-article:16755175 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16755175 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:16755175 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16755175 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16755175 | pubmed:pagination | 232-9 | lld:pubmed |
| pubmed-article:16755175 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:meshHeading | pubmed-meshheading:16755175... | lld:pubmed |
| pubmed-article:16755175 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16755175 | pubmed:articleTitle | Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? | lld:pubmed |
| pubmed-article:16755175 | pubmed:affiliation | Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. elin@mdanderson.org | lld:pubmed |
| pubmed-article:16755175 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16755175 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16755175 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16755175 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16755175 | lld:pubmed |
